Male breast cancer: a disease distinct from female breast cancer
Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …
Breast cancer in men
SH Giordano - New England Journal of Medicine, 2018 - Mass Medical Soc
Breast Cancer in Men Breast cancer in men accounts for about 1% of all breast cancers and
is mainly estrogen-receptor–positive. Few prospective studies of treatment in men have …
is mainly estrogen-receptor–positive. Few prospective studies of treatment in men have …
Genomic characterization of metastatic breast cancers
Metastasis is the main cause of death for patients with breast cancer. Many studies have
characterized the genomic landscape of breast cancer during its early stages. However …
characterized the genomic landscape of breast cancer during its early stages. However …
Organoid models of human liver cancers derived from tumor needle biopsies
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the second
most frequent cause of cancer-related mortality worldwide. The multikinase inhibitor …
most frequent cause of cancer-related mortality worldwide. The multikinase inhibitor …
[HTML][HTML] Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Background Male breast cancer (BC) is rare, managed by extrapolation from female BC. The
International Male BC Program aims to better characterize and manage this disease. We …
International Male BC Program aims to better characterize and manage this disease. We …
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer
Purpose: Resistance to platinum-based chemotherapy or PARP inhibition in germline
BRCA1 or BRCA2 mutation carriers may occur through somatic reversion mutations or …
BRCA1 or BRCA2 mutation carriers may occur through somatic reversion mutations or …
Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments
Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …
million new cases in world in 2018. It is the second leading cause of death from cancer in …
Male breast cancer: an update
Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …
incidence has increased worldwide. Risk factors include increased longevity, obesity …
The genetic landscape of endometrial clear cell carcinomas
Clear cell carcinoma of the endometrium is a rare type of endometrial cancer that is
generally associated with an aggressive clinical behaviour. Here, we sought to define the …
generally associated with an aggressive clinical behaviour. Here, we sought to define the …
Male breast cancer in the United States: treatment patterns and prognostic factors in the 21st century
Background Male breast cancer (MBC) is a rare disease for which there is limited
understanding of treatment patterns and prognostic factors. Methods Men with TNM stage I …
understanding of treatment patterns and prognostic factors. Methods Men with TNM stage I …